Specialist

GLP-1 Audit Integration & Non-Invasive Alternatives

CMA & CPD Accredited

GLP-1 Audit Integration & Non-Invasive Alternatives CMA CPD Accredited| Delivered by Lea Lawrence

 

Technology, Testing, Treatments & Training for Transformation.

 

Global Relevance, according to The Lancet (2023), more than half of the world’s adult population will be overweight or obese by 2050. This staggering projection highlights the urgent need for safe, sustainable, and inclusive approaches to weight management. GLP-1 and GIP medications offer short-term solutions, but they also present risks including muscle loss, nutritional deficiencies, and psychological challenges.


This audit addresses those gaps by equipping practitioners with evidence-based, CMA-accredited protocols for both post-medication aftercare and non-invasive alternatives. It empowers practitioners to support patients holistically, physically, emotionally, and energetically — offering solutions “lighter than a feather” that restore well-being, protect dignity, and contribute meaningfully to global wellness goals.

 

The Global Demand

 

Over 35 million people worldwide now use GLP-1 medications such as Ozempic, Wegovy, and Mounjaro — a number projected to surpass 70 million by 2030. The spa and aesthetics industry is shifting rapidly. Clients no longer want surface beauty — they want transformational, integrative treatments. In the UK, 1 in 12 women are now using weight-loss injectables.

 

These clients are actively seeking therapists who can deliver high-touch protocols that address both physical and emotional wellbeing concerns which require non injectable treatments.


Before you add any more treatments let us identify what is missing in your protocols.


GLP-1 clients are already in your clinic and the question is: Are you equipped to treat them properly?


THE PROBLEM

Clinics are seeing increasing numbers of clients using:


•  Ozempic  •  Wegovy  •  Mounjaro


THE REALITY

GLP-1 clients are not presenting with simple concerns.


But most treatments are:


treating surface symptoms only

addressing weight loss, not systemic impact

applying standard protocols to non-standard physiology

overlooking progressive changes beneath the surface

reacting late instead of intervening early

losing long-term client value without realising why


The issue is not visibility it is misinterpretation.


WHAT YOU DON’T SEE

GLP-1 therapies create multi-system changes, not isolated effects.


Clients may present with:


METABOLIC DISRUPTION

•  slowed or altered metabolic response  •  energy instability  •  reduced adaptive capacity


 STRUCTURAL & SKIN CHANGES

•  volume loss (“GLP-1 face”)  •  muscle loss (“GLP-1 body”)  •  reduced elasticity  •  thinning tissue and altered repair response


NUTRITIONAL DEPLETION

•  micronutrient deficiencies  •  impaired absorption  •  cellular undernourishment


DIGESTIVE & GUT IMPACT
•  slowed gastric emptying  •  digestive discomfort  •  microbiome imbalance


HORMONAL & FATIGUE PATTERNS
•  endocrine disruption  •  fatigue and burnout  •  reduced resilience

 

THE CRITICAL POINT


These changes:

•  do not present clearly at consultation  •  are often misread as “normal weight loss effects”  •  develop progressively, not instantly


Which means by the time they are visible — they are already established


WITHOUT STRUCTURED EVALUATION


You are:

•  applying treatments without full context  •  missing underlying drivers  •  under-delivering results  •  limiting client retention and spend


Not through lack of skill but through lack of system visibility


THE TRUTH

GLP-1 clients require a different model of care.


Not more treatments, but a higher level of care:

•  Better interpretation  •  Better structure  •  Better timing


Without structured evaluation, you are not optimising outcomes you are reacting to symptoms.


But most are:

•  treating symptoms only  •  missing underlying changes  •  not adjusting protocols  •  losing long-term client value


WHAT YOU DON’T SEE


GLP-1 clients present with:

•  metabolic shifts  •  structural skin, body & hair changes  •  nutritional depletion  •  fatigue patterns


These are not visible at consultation level.

Without structured evaluation: you are guessing.


WHAT THE AUDIT DOES


Our GLP-1 Audit Integration & Non-Invasive Alternatives CMA & CPD Accredited session identifies:


•  gaps in your current client approach  •  missed revenue opportunities  •  misalignment in treatments

•  areas requiring structured support


This is not theory. This is applied clinical insight.


WHAT YOU RECEIVE

•  Review of current services & positioning  •  GLP-1 client pathway analysis  •  Identification of missing elements


Recommended structure options:

• testing  •  skincare  •  treatments  •  patches  •  programmes


WHY THIS MATTERS


Without this:

•  client plateau  •  results don’t hold  •  therapist and practitioners underperform


With this:

•  clients stay longer  •  spend more  •  see better outcomes


COMMERCIAL IMPACT


Most therapists or practitioners: offer treatments in isolation

After audit: structured pathways generate: £500.00 – £1,500.00+ per client


GLP-1 Audit Integration & Non-Invasive Alternatives CMA & CPD Accredited™ £595.00


•  Single session  •  High-level evaluation  •  Immediate application


 WHAT HAPPENS NEXT


Following the audit, therapist and practitioners may choose to:


•  implement product systems  •  integrate patches  •  introduce testing modules  •  progress into training or certification 


Because you don’t need more treatments - you need the right structure, technology & prestige.


WHAT HAPPENS NEXT


After booking:


  1. You will be contacted to confirm your session

2. Your current services and positioning will be reviewed

3. You will receive a structured evaluation with clear next steps


This is designed for immediate application.


WHAT YOU LEAVE WITH (VALUE, NOT TASKS)


•  clarity on what is missing  •  a structured client pathway  •  defined opportunities for increased outcomes and revenue


Not theory; Not generic advice, but a clear direction.

“Most clinics recover this investment from a single client pathway.”


RISK REMOVAL


•  No obligation to continue  •  Suitable for all practitioner levels  •  Designed to integrate with your existing services 


Due to the level of detail involved, a limited number of audits are completed each week.


“If you are currently treating GLP-1 clients, this is the point where you stop guessing — and start structuring.”


Identify What Your Clinic Is Missing — Before It Affects Results


•  immediate clarity on your current client pathways  •  insight into what is being missed  •  a structured direction to improve outcomes and retention 


This is not ongoing training.

This is a focused evaluation of your current practice.


The GLP-1Audit Integration & Non-Invasive Alternatives CMA & CPD Accredited™

•  1:1 practitioner evaluation  •  full pathway review  •  structured recommendations 

£595.00


Due to the level of detail involved, a limited number of audits are completed each week.

If you are currently treating GLP-1 clients, this is no longer optional, it is essential.


“Most clinics wait until results decline this identifies the issue before that happens.”

Discovery - GLP-1 Audit & Integration